by admin | Apr 11, 2021 | Press Release
PLEASANTON, CA / ACCESSWIRE / March 25, 2021 / Movano Inc. (NASDAQ:MOVE), a health technology company designing devices that empower individuals to optimize their health in order to prevent and better manage chronic diseases, has closed its previously announced...
by admin | Apr 11, 2021 | Press Release
DEER PARK, Ill., Oct. 16, 2020 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative treatments for rare pediatric diseases, today announced the closing of its previously...
by admin | Apr 11, 2021 | Press Release
After announcing $10M in bridge funding in July, the company raised an additional $2.5M to progress the development of its wearable non-invasive continuous glucose monitor PLEASANTON, Calif., Aug. 28, 2020 (GLOBE NEWSWIRE) — Movano Inc., a health-focused technology...
by admin | Apr 11, 2021 | Press Release
Underwriter Exercises Its Overallotment Option in Full SEATTLE, Aug. 24, 2020 /PRNewswire/ — ClearSign Technologies Corporation (“ClearSign” or “the Company”) (Nasdaq: CLIR), an emerging leader in industrial combustion and sensing technologies that improve energy,...
by admin | Apr 11, 2021 | Press Release
August 11, 2020 at 9:00 AM EDTDownload PDF AUSTIN, Texas–(BUSINESS WIRE)–Aug. 11, 2020– TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin...
by admin | Aug 3, 2021 | Press Release
Company’s needle-free wearable technology will provide painless, real-time glucose readings at the glance of a wrist | July 14, 2020 16:58 ET | Source: Movano Inc | PLEASANTON, Calif., July 14, 2020 (GLOBE NEWSWIRE) — Movano Inc., a health-focused...